US SB3092 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on December 18 2019 - 25% progression, died in committee
Action: 2019-12-18 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 18 2019 - 25% progression, died in committee
Action: 2019-12-18 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes.
Title
Expanding Access to Low-Cost Generics Act of 2019
Sponsors
Sen. Tina Smith [D-MN] | Sen. Mike Braun [R-IN] |
History
Date | Chamber | Action |
---|---|---|
2019-12-18 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/3092/all-info |
Text | https://www.congress.gov/116/bills/s3092/BILLS-116s3092is.pdf |